378 related articles for article (PubMed ID: 18680173)
21. Issues of simultaneous tests for noninferiority and superiority.
Ng TH
J Biopharm Stat; 2003 Nov; 13(4):629-39; discussion 641-62. PubMed ID: 14584713
[TBL] [Abstract][Full Text] [Related]
22. The issue of multiplicity in noninferiority studies.
Ke C; Ding B; Jiang Q; Snapinn SM
Clin Trials; 2012 Dec; 9(6):730-5. PubMed ID: 22879575
[TBL] [Abstract][Full Text] [Related]
23. Issues with statistical risks for testing methods in noninferiority trial without a placebo ARM.
Hung HM; Wang SJ; O'Neill R
J Biopharm Stat; 2007; 17(2):201-13. PubMed ID: 17365218
[TBL] [Abstract][Full Text] [Related]
24. Evaluating co-primary endpoints collectively in clinical trials.
Li QH
Biom J; 2009 Feb; 51(1):137-45. PubMed ID: 19219905
[TBL] [Abstract][Full Text] [Related]
25. Type I error and power in noninferiority/equivalence trials with correlated multiple endpoints: an example from vaccine development trials.
Kong L; Kohberger RC; Koch GG
J Biopharm Stat; 2004 Nov; 14(4):893-907. PubMed ID: 15587971
[TBL] [Abstract][Full Text] [Related]
26. Gatekeeping procedures with clinical trial applications.
Dmitrienko A; Tamhane AC
Pharm Stat; 2007; 6(3):171-80. PubMed ID: 17583553
[TBL] [Abstract][Full Text] [Related]
27. Non-parametric assessment of non-inferiority with censored data.
Freitag G; Lange S; Munk A
Stat Med; 2006 Apr; 25(7):1201-17. PubMed ID: 16345041
[TBL] [Abstract][Full Text] [Related]
28. Simultaneous test for superiority and noninferiority hypotheses in active-controlled clinical trials.
Tsong Y; Zhang J
J Biopharm Stat; 2007; 17(2):247-57. PubMed ID: 17365221
[TBL] [Abstract][Full Text] [Related]
29. A mixed approach for proving non-inferiority in clinical trials with binary endpoints.
Rousson V; Seifert B
Biom J; 2008 Apr; 50(2):190-204. PubMed ID: 18311852
[TBL] [Abstract][Full Text] [Related]
30. A more powerful test based on ratio distribution for retention noninferiority hypothesis.
Deng L; Chen G
J Biopharm Stat; 2013 Mar; 23(2):346-60. PubMed ID: 23437943
[TBL] [Abstract][Full Text] [Related]
31. Re-formulating non-inferiority trials as superiority trials: The case of binary outcomes.
Durkalski VL; Berger VW
Biom J; 2009 Feb; 51(1):185-92. PubMed ID: 19197960
[TBL] [Abstract][Full Text] [Related]
32. Analysis of time-to-event data under a two-stage survival adaptive design in clinical trials.
Lu Q; Tse SK; Chow SC
J Biopharm Stat; 2010 Jul; 20(4):705-19. PubMed ID: 20496201
[TBL] [Abstract][Full Text] [Related]
33. An efficient method for accommodating potentially underpowered primary endpoints.
Li J; Mehrotra DV
Stat Med; 2008 Nov; 27(26):5377-91. PubMed ID: 18759248
[TBL] [Abstract][Full Text] [Related]
34. Some controversial multiple testing problems in regulatory applications.
Hung HM; Wang SJ
J Biopharm Stat; 2009; 19(1):1-11; discussion 12-41. PubMed ID: 19127460
[TBL] [Abstract][Full Text] [Related]
35. Multiple testing of noninferiority hypotheses in active controlled trials.
Hung HM; Wang SJ
J Biopharm Stat; 2004 May; 14(2):327-35. PubMed ID: 15206530
[TBL] [Abstract][Full Text] [Related]
36. Method of balanced adjustment in testing co-primary endpoints.
Kordzakhia G; Siddiqui O; Huque MF
Stat Med; 2010 Aug; 29(19):2055-66. PubMed ID: 20683896
[TBL] [Abstract][Full Text] [Related]
37. Constructing multiple test procedures for partially ordered hypothesis sets.
Edwards D; Madsen J
Stat Med; 2007 Dec; 26(28):5116-24. PubMed ID: 17476650
[TBL] [Abstract][Full Text] [Related]
38. Semiparametric bayesian testing procedure for noninferiority trials with binary endpoints.
Osman M; Ghosh SK
J Biopharm Stat; 2011 Sep; 21(5):920-37. PubMed ID: 21830923
[TBL] [Abstract][Full Text] [Related]
39. Marginal modeling of binary cross-over data.
Becker MP; Balagtas CC
Biometrics; 1993 Dec; 49(4):997-1009. PubMed ID: 8117910
[TBL] [Abstract][Full Text] [Related]
40. A simple meta-analytic approach for using a binary surrogate endpoint to predict the effect of intervention on true endpoint.
Baker SG
Biostatistics; 2006 Jan; 7(1):58-70. PubMed ID: 15972889
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
